Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 11—November 2016
Research

Ambulatory Pediatric Surveillance of Hand, Foot and Mouth Disease as Signal of an Outbreak of Coxsackievirus A6 Infections, France, 2014–2015

Audrey MirandComments to Author , François Vié le Sage, Bruno Pereira, Robert Cohen, Corinne Levy, Christine Archimbaud, Hélène Peigue-Lafeuille, Jean-Luc Bailly, and Cécile Henquell
Author affiliations: Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France (A. Mirand, B. Pereira, C. Archimbaud, H. Lafeuille, J.-L. Bailly, C. Henquell); Université d’Auvergne, Clermont-Ferrand (A. Mirand, C. Archimbaud, H. Peigue-Lafeuille, J.-L. Bailly, C. Henquell); Association Française de Pédiatrie Ambulatoire, Bagnols-sur-Cèze, France (F. Vié le Sage); Association Clinique et Thérapeutique Infantile du Val de Marne, Saint Maur des Fossés, France (R. Cohen, C. Levy); Université Paris Est, Créteil, France (R. Cohen, C. Levy)

Main Article

Table 2

Demographic and clinical features associated with CV-6 infections in 4 age groups of patients, France, April 2014–March 2015*

Characteristic
<1 y, n = 63
1–2 y, n = 146
2–3 y, n = 50
>3 y, n = 26
p value†
Male sex, no. (%) 35/62 (56.4) 80/146 (55.5) 26/49 (53.1) 10/25 (40 0.52
Time between onset and consultation, d, mean (SD)‡
1.84 (1.31)
2.27 (1.43)
1.87 (1.48)
2.46 (2.02)
0.09
Signs and symptoms, no. (%)
Fever 54 (85.7) 105 (71.92) 38 (76) 22 (84.6) 0.13
Oral ulcerations 17 (27) 53 (36.3) 19 (38) 12 (46.1) 0.32
Perioral ulcerations 18 (28.57) 67 (45.9) 25 (50) 15 (57.7) 0.003
Eruption 53 (84.1) 143 (97.9) 45 (90) 26 (100) 0.001
Vesicular eruption 43 (71.7) 120 (83.9) 41 (83.7) 21 (84) 0.21
Nonvesicular eruption
20 (31.7)
55(37.7)
11 (22)
7 (26.9)
0.20
Localizations of eruption, no. (%)
Palms 41 (65.1) 96 (65.75) 33 (66) 20 (76.9) 0.71
Soles 34 (54) 86 (58.9) 24 (48) 16 (61.5) 0.53
Buttocks 29 (46) 100 (68.5) 30 (60) 12 (46.1) 0.009
Elbows or knees 15 (23.8) 49 (33.6) 16 (32) 10 (38.5) 0.46
Lower limbs 20 (31.8) 75 (51.4) 26 (52) 10 (38.5) 0.04
Upper limbs 8 (12.7) 55 (37.7) 17 (34) 3 (11.5) <0.001
Generalized eruption 9 (14.3) 14 (9.6) 3 (6) 1 (3.9) 0.41
Trunk ND ND ND ND ND
Face, including perioral ulcerations
21 (33.3)
70 (48)
27 (54)
15 (57.7)
0.07
Diagnosis, no. (%)
Typical HFMD§ 10 (15.9) 17 (11.6) 3 (6) 2 (7.7) 0.38
Atypical HFMD 30 (47.6)¶ 100 (68.5)¶ 32 (64) 19 (73.1)¶ 0.02
Herpangina 45 (71.4) 76 (52.1) 29 (58) 15 (57.7) 0.08
Herpangina alone
9 (14.3)
2 (1.4)
4 (8)
0
0.001
Other signs, no. (%)
Digestive signs 7 (11.1) 16 (11) 10 (20) 5 (19.2) 0.28
Ear, nose, and throat signs 4 (6.4) 18 (12.3) 3 (6) 2 (7.7) 0.41
Respiratory signs ND ND ND ND ND

*For 1 patient, age was not known. CV-A6, coxsackievirus A6; HFMD, hand, foot and mouth disease; ND, not determined because of low sample size (<15 patients total).
†Significant p values (p<0.05) are indicated in bold type.
‡Time from symptom onset and consultation was available for 525 episodes of enterovirus infection.
§Typical HFMD was defined as the presence of >2 of the following signs: oral ulcerations, eruption on palms, soles, buttocks, knees, or elbows, excluding any other localization. Atypical HFMD was defined by the presence of >2 of those signs plus the involvement of another anatomic site.
¶Indicates significant differences between age groups.

Main Article

Page created: October 18, 2016
Page updated: October 18, 2016
Page reviewed: October 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external